Paris Saclay Cancer Cluster : une ambition mondiale pour l’oncologie française.

Press release – Inserm press room Paris Saclay Cancer Cluster : une ambition mondiale pour l’oncologie française. Link : https://presse.inserm.fr/en/lassociation-paris-saclay-cancer-cluster-annonce-sa-creation-officielle-et-la-nomination-de-ses-dirigeants/44656/

Other contents In the same category :

Cancer Voir tout Institutional and special event Voir tout

A Novel Immunotherapy Approach Redirects Epstein-Barr Antibodies toward Disease-Causing Cells

Monoclonal antibody therapy can be very effective in treating numerous illnesses, such as cancers, chronic inflammatory conditions, and infectious diseases. Researchers from Inserm, Université de Paris, Sorbonne Université and CNRS1 have designed and tested a new immunotherapy approach that uses pre-existing antibodies ...

Improving immunotherapies for blood cancers: real-time exploration in the tumor

Monoclonal antibodies are part of the therapeutic arsenal for eliminating cancer cells. Some make use of the immune system to act and belong to a class of treatment called "immunotherapies." But how do these antibodies function within the tumor? And how can ...

Medias